Bringing the fundamentals into focus…
Back to Oruka Therapeutics, Inc.
How Oruka Therapeutics, Inc. stacks up
ORKA · against 206 other Healthcare companies of similar size
Overall
45/ 100
Below the middle of the pack.
Ranked #153 of 207 · scores higher than 26% of peers
Bars: peers in each 10-point band of the overall score30 peers with an overall score of 40–49, including ORKA · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around ORKA| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | 100 | 0 / 2 | ||
| 2 | 37.3B HKD (≈$4.8B) | 90 | 99 | 98 | 84 | 0 / 2 | |
| 3 | 921.9B INR (≈$11.1B) | 82 | 84 | 80 | 94 | 0 / 2 | |
| 4 | 936.1B JPY (≈$6.4B) | 80 | 65 | 86 | 94 | 0 / 2 | |
| 5 | 40.3B SEK (≈$4.0B) | 79 | 43 | 84 | 97 | 0 / 2 | |
| 143 | 303.5B INR (≈$3.6B) | 47 | 42 | 60 | 59 | 2 / 2 | |
| 151 | 4.7B USD | 46 | 8 | 75 | 20 | 0 / 2 | |
| 151 | 4.0B USD | 46 | 49 | 64 | 41 | 2 / 2 | |
| 153 | 64.1B CNY (≈$9.0B) | 45 | 56 | 13 | 60 | 1 / 2 | |
| 153 | 6.6B USD | 45 | 8 | — | 26 | 0 / 2 | |
| 155 | 6.2B USD | 44 | 8 | 82 | 10 | 0 / 2 | |
| 155 | 4.2B USD | 44 | 8 | 93 | 23 | 1 / 2 | |
| 157 | 10.0B USD | 43 | 52 | 25 | 50 | 1 / 2 | |
| 157 | 7.2B USD | 43 | 48 | 57 | 40 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score